➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Medtronic
McKinsey
Harvard Business School
Johnson and Johnson

Last Updated: April 22, 2021

DrugPatentWatch Database Preview

TIROSINT-SOL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Tirosint-sol, and when can generic versions of Tirosint-sol launch?

Tirosint-sol is a drug marketed by Institut Biochimique and is included in one NDA. There is one patent protecting this drug.

This drug has nine patent family members in eight countries.

The generic ingredient in TIROSINT-SOL is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Drug patent expirations by year for TIROSINT-SOL
Drug Prices for TIROSINT-SOL

See drug prices for TIROSINT-SOL

Recent Clinical Trials for TIROSINT-SOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Mercy Hospital Kansas CityPhase 4
IBSA Institut Biochimique SAPhase 4
Meyer Children's HospitalPhase 4

See all TIROSINT-SOL clinical trials

US Patents and Regulatory Information for TIROSINT-SOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Institut Biochimique TIROSINT-SOL levothyroxine sodium SOLUTION;ORAL 206977-001 Dec 15, 2016 RX Yes No   Get Started Free   Get Started Free Y   Get Started Free
Institut Biochimique TIROSINT-SOL levothyroxine sodium SOLUTION;ORAL 206977-007 Dec 15, 2016 RX Yes No   Get Started Free   Get Started Free Y   Get Started Free
Institut Biochimique TIROSINT-SOL levothyroxine sodium SOLUTION;ORAL 206977-004 Dec 15, 2016 RX Yes No   Get Started Free   Get Started Free Y   Get Started Free
Institut Biochimique TIROSINT-SOL levothyroxine sodium SOLUTION;ORAL 206977-012 Dec 15, 2016 RX Yes Yes   Get Started Free   Get Started Free Y   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Dow
Boehringer Ingelheim
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.